Cambridge, Massachusetts-based molecular diagnostics startup, NuProbe, announced it has raised $11 million Series A funding round to expand reach of precision medicine and continue the development of ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases. The round was co-led […]